Navigation Links
VerifyNow Clopidogrel Assay

ProductsVerifyNow Clopidogrel Assay
Company Accumetrics
Item VerifyNow Clopidogrel Assay
Features THE ISSUE:
  • Platelet aggregation pays a key role in the pathogenesis of thrombosis and acute coronary disease
  • Clopidogrel inhibits platelet aggregation
  • Patients exhibit a variable response to clopidogrel
THE IMPLICATION:
  • Maximum anti-platelet effects of clopidogrel may not be obtained with standard dosage.
  • Up to 30% of patients may be resistant to the effects of clopidogrel.1,2
  • Patient assessment may be required prior to initiation of procedures where clopidogrel is given.
  • Pre-surgical testing of platelet function can assess bleeding risk.
THE SOLUTION: VerifyNow Clopidogrel
  • A new rapid platelet function assay, VerifyNow Clopidogrel, has been developed by Accumetrics. The assay is specific to the effects of drugs such as clopidogrel.
  • The assay is currently available for Research Use Only (RUO); not for use in diagnostic procedures.
Description The VerifyNow Clopidogrel Assay measures changes in platelet function in response to patients taking Clopidogrel (Plavix). It uses a specific activator for the P2Y12 pathway, which clopidogrel inhibits. The assay has not been cleared by the FDA, however, the assay is available for Research Use Only (RUO) settings.
Info Accumetrics
Customer Service: (800) 643-1640
Web site: http://www.accumetrics.com

Related medicine products :

1. VerifyNow System
2. VerifyNow Aspirin Assay
3. VerifyNow IIb/IIIa Assay
4. VerifyNow (Ultegra) System
5. Uric Acid Enzymatic Assay
6. Lithium Enzymatic Assay Kit
7. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
8. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
9. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
10. Procleix HIV-1/HCV Assay
11. VERSANT HIV RNA 3.0 Assay (bDNA)
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
... fungal pathogens are Candida spp. ... pathogens, including Fusarium spp., Trichosporon ... immitis, Histoplasma capsulatum, Sporothrix schenckii, ... The (1-3)--D-glucan produced by these ...
... SYSCAN3® Hospital Test Kit is a multi-well ELISA ... in a standard serology laboratory without the need ... specific antigen preparation from Candida albicans. Our SYSCAN3 ... the presence of antibodies to Candida in the ...
Rapid reagent impregnated disk test for presumptive identification of Candida albicans....
Medicine Products:
(Date:5/26/2017)... ... 26, 2017 , ... Mediaplanet is proud to announce the launch of its ... will educate readers on how to take care of all aspects of their skin. ... on melanoma. Dancing with the Stars professional, Witney Carson, shares her journey with the ...
(Date:5/26/2017)... ... May 26, 2017 , ... The Radiology Business ... focus on current legislative activity and the latest regulatory concerns impacting RBMA members. ... Sept. 10, and will continue through Monday, Sept. 11, at the Ritz-Carlton, Tysons ...
(Date:5/26/2017)... MN (PRWEB) , ... May 26, 2017 , ... A ... U.S. states with the healthiest seniors are located in the Midwest. With the average ... more and more people are concerned with both the quality and affordability of where ...
(Date:5/26/2017)... ... ... On May 24, the Congressional Budget Office (CBO) projected that the amended ... would result in 23 million Americans losing their health insurance by 2026 as compared ... Affordable Care Act (ACA). , “It is clear from the CBO analysis that ...
(Date:5/26/2017)... ... May 26, 2017 , ... Silver Birch of Hammond, a new assisted ... more than four acres of land at 5620 Sohl Avenue in Hammond, serves older ... building includes 125 studio and one-bedroom apartments. Each of the private apartments at Silver ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a ... and developing novel compounds to treat Parkinson,s disease (PD), ... study is a Phase 1/2a randomized, controlled, multicenter study involving ... It will enroll 50 patients over a 9-to-12-month period. The ... in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... on the development of oral drug delivery systems, ... has granted Oramed a patent titled, "Methods and ... covers Oramed,s invention of an oral glucagon-like peptide-1 ... hormone that stimulates the secretion of insulin from ...
Breaking Medicine Technology: